Overall Research Interests
Dr Hwa’s overall interests have been in translational studies (from bench to bedside) in the broad area of cardiovascular disease. The Hwa lab studies have transitioned across many fields from fundamental protein structure function, to molecular signaling, to cellular dysfunction, and to clinical disease. The goal is to fearlessly study platelets with multi-dimensional approaches to develop new mechanistic insights and therapeutic strategies in platelet related diseases.
Why Platelets?
Copy Link
Versatile platelet functions in health and diseases (Image adapted from Tyagi, Jain & Hwa et al, Nature CVR, 2022).
Platelets are exquisitely sensitive to blood stressors (e.g. high glucose or inflammation) and can launch a rapid response, either by themselves or by recruiting other cells. They contain hundreds of substances including growth factors, cytokines which are released to influence other cells. Every single one of these are needed under particular stress environments. The key now is to uncover the individual stress responses and how to modulate them. Platelets are in essence the “vigilantes” of the blood stream. Stream. Translational studies bridging basic and clinical science is the path to more effective personalized and targeted therapeutics.
Current Studies
Copy Link
Analysis of platelets using mass cytometry and spectral flow identifies many platelet subtypes.
A focus of our laboratory is to investigate platelet heterogeneity across different populations and diseases. This includes sickle cell disease and pediatric sepsis. We are utilizing high-dimensional single-cell technologies to characterize distinct functional subsets of platelets and define their mechanistic contributions to inflammatory and thrombotic vascular diseases.
Protein aggregates (yellow arrows) can be found in platelets treated with DTT (stressor that reduces disulfide bonds).
We investigate how platelet proteostasis shapes platelet functional phenotype, with a particular focus on the unfolded protein response. The work examines how these mechanisms contribute to cardiovascular disease and neurodegenerative disorders, with the goal of identifying new therapeutic strategies beyond current antiplatelet approaches.
The image shows an IF micrograph of human platelets (green stained) containing TLT-1 protein (red stained) in granules mobilizing to the platelet surface (from Tyagi et al, JEM, 2023).
We are also interested in platelet mediated immune functions. We are exploring the molecular basis of platelet-dysfunction and platelet -T cell crosstalk and its pathological consequences through human and mouse studies.